These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 15896452

  • 1. Chemopreventive and therapeutic effects of curcumin.
    Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M.
    Cancer Lett; 2005 Jun 08; 223(2):181-90. PubMed ID: 15896452
    [Abstract] [Full Text] [Related]

  • 2. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.
    Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M.
    Biochem Pharmacol; 2008 Dec 01; 76(11):1340-51. PubMed ID: 18755156
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
    Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N.
    Cancer Lett; 2005 Jun 16; 224(1):53-65. PubMed ID: 15911101
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of curcumin action: signal transduction.
    Shehzad A, Lee YS.
    Biofactors; 2013 Jun 16; 39(1):27-36. PubMed ID: 23303697
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB.
    Mol Pharmacol; 2006 Jan 16; 69(1):195-206. PubMed ID: 16219905
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa.
    Shankar S, Srivastava RK.
    Carcinogenesis; 2007 Jun 16; 28(6):1277-86. PubMed ID: 17277231
    [Abstract] [Full Text] [Related]

  • 15. Curcumin: the story so far.
    Sharma RA, Gescher AJ, Steward WP.
    Eur J Cancer; 2005 Sep 16; 41(13):1955-68. PubMed ID: 16081279
    [Abstract] [Full Text] [Related]

  • 16. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells.
    Karmakar S, Banik NL, Patel SJ, Ray SK.
    Neurosci Lett; 2006 Oct 16; 407(1):53-8. PubMed ID: 16949208
    [Abstract] [Full Text] [Related]

  • 17. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S, Srivastava RK.
    Int J Oncol; 2007 Apr 16; 30(4):905-18. PubMed ID: 17332930
    [Abstract] [Full Text] [Related]

  • 18. Curcumin inhibits telomerase activity in human cancer cell lines.
    Cui SX, Qu XJ, Xie YY, Zhou L, Nakata M, Makuuchi M, Tang W.
    Int J Mol Med; 2006 Aug 16; 18(2):227-31. PubMed ID: 16820928
    [Abstract] [Full Text] [Related]

  • 19. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE.
    Clin Cancer Res; 2005 Oct 15; 11(20):7490-8. PubMed ID: 16243823
    [Abstract] [Full Text] [Related]

  • 20. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
    Shehzad A, Wahid F, Lee YS.
    Arch Pharm (Weinheim); 2010 Sep 15; 343(9):489-99. PubMed ID: 20726007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.